{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hyperhidrosis/how-up-to-date-is-this-topic/update/","result":{"pageContext":{"chapter":{"id":"37a4f575-9e64-5591-9459-613a50da6a5b","slug":"update","fullItemName":"Update","depth":2,"htmlHeader":"<!-- begin field 704f82aa-765e-44e8-b125-21b608ee9dbd --><h2>Update</h2><!-- end field 704f82aa-765e-44e8-b125-21b608ee9dbd -->","summary":null,"htmlStringContent":"<!-- begin item 6151e424-00df-4d09-af59-19d1574cef0f --><!-- end item 6151e424-00df-4d09-af59-19d1574cef0f -->","topic":{"id":"d2b54f08-d9cb-5147-a5aa-27e00b5cfd82","topicId":"9dacba69-b1b5-408f-a26d-a8e884033a25","topicName":"Hyperhidrosis","slug":"hyperhidrosis","lastRevised":"Last revised in May 2018","chapters":[{"id":"51b68ff2-e22f-5146-98b1-ed247449fada","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"d247fa3c-c9d7-571f-9348-9d3a5b9a827f","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"3db15061-64ce-5067-8778-049202743014","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"5d7852f4-9b06-5320-86de-ee56104314fc","slug":"changes","fullItemName":"Changes"},{"id":"37a4f575-9e64-5591-9459-613a50da6a5b","slug":"update","fullItemName":"Update"}]},{"id":"6608a015-2abe-5be8-882a-844689719b29","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"2b31616d-6688-52e8-abfe-1c1e9567773c","slug":"goals","fullItemName":"Goals"},{"id":"164bcdd9-2d27-5afc-8857-f691d732e91a","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"f04b5274-abcd-5e07-9d0e-218d1b25b64a","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"35e097f0-6a28-54ce-91f0-09584dff79fd","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"0c245ac4-9908-5ec7-9443-c8d80afba273","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"479a66f8-4820-5838-babb-6b95327bf868","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"e78f871f-1030-583b-b3a3-fd5932d63577","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"f573ecee-b6e5-56a9-b610-ad80005d58b7","slug":"definition","fullItemName":"Definition"},{"id":"5105b210-71a6-505f-9fe7-96123ea1beba","slug":"causes","fullItemName":"Causes"},{"id":"3064f161-ea2d-5e49-9dbb-092faa5d5f71","slug":"prevalence","fullItemName":"Prevalence"},{"id":"2e2ec09e-2d90-5f72-b368-813dea5aee6e","slug":"complications","fullItemName":"Complications"},{"id":"8132bf09-7bc9-55ce-8d34-d18405a2c171","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"13f16bec-4872-59e8-9996-2d88a053d081","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"dfa50ec8-3fda-51b5-9903-61e58cc06753","slug":"assessment","fullItemName":"Assessment"}]},{"id":"45eb7b55-769c-50ef-9ce2-44c27469518c","fullItemName":"Management","slug":"management","subChapters":[{"id":"e0426c02-494d-544f-ac4b-5a344571652a","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"f83d14e6-24e3-513f-8d39-8b68803222b0","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"00e65205-feb9-59d3-8035-446868d1caab","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"b7466396-123d-5050-8dd8-88ec7ce286f7","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"0574994c-afef-578e-ab8a-e3d78c0757e3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"68b43c06-7da3-5e66-ae57-bc294e301587","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"67e38cee-224f-54bd-ad61-431d5cc9c006","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"373675d4-86fc-5734-962f-d2aad8d56169","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"26f4cbb7-dfc9-5c02-9786-950141a26758","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"3db15061-64ce-5067-8778-049202743014","slug":"how-up-to-date-is-this-topic","fullItemName":"How up-to-date is this topic?"},"subChapters":[{"id":"87f34fb9-d76d-54dc-9ff8-904dda5d2bd9","slug":"new-evidence","fullItemName":"New evidence","depth":3,"htmlHeader":"<!-- begin field 5b0d1ab6-2a39-4543-be68-796e3d15e713 --><h3>New evidence</h3><!-- end field 5b0d1ab6-2a39-4543-be68-796e3d15e713 -->","summary":null,"htmlStringContent":"<!-- begin item 7dbafcb8-1fb6-45e3-b4bd-a06a9839206b --><!-- begin field 99c80f51-9c52-472b-8a67-1df5a8fd2af5 --><h3>Evidence-based guidelines</h3><!-- end field 99c80f51-9c52-472b-8a67-1df5a8fd2af5 --><!-- begin field 09be9b13-074e-4202-ad4c-7e5bf743ac95 --><p>No new evidence-based guidelines since 1 May 2018.</p><!-- end field 09be9b13-074e-4202-ad4c-7e5bf743ac95 --><!-- begin field 03b5b26b-9f4d-4140-bdb4-38f720077596 --><h3>HTAs (Health Technology Assessments)</h3><!-- end field 03b5b26b-9f4d-4140-bdb4-38f720077596 --><!-- begin field bdfbb55b-3da9-461f-b5a5-c5826dad04b0 --><p>No new HTAs since 1 May 2018.</p><!-- end field bdfbb55b-3da9-461f-b5a5-c5826dad04b0 --><!-- begin field 3dacb644-79a7-403b-8605-ba47f18c3854 --><h3>Economic appraisals</h3><!-- end field 3dacb644-79a7-403b-8605-ba47f18c3854 --><!-- begin field b2c3ce2b-1514-4cc2-b664-290d39920263 --><p>No new economic appraisals relevant to England since 1 May 2018.</p><!-- end field b2c3ce2b-1514-4cc2-b664-290d39920263 --><!-- begin field 8a92d0e6-ef1a-4016-9abe-256660d5e48e --><h3>Systematic reviews and meta-analyses</h3><!-- end field 8a92d0e6-ef1a-4016-9abe-256660d5e48e --><!-- begin field 52a74273-d0ea-4994-abf7-bc4d969470f0 --><p>No new systematic review or meta-analysis since 1 May 2018.</p><!-- end field 52a74273-d0ea-4994-abf7-bc4d969470f0 --><!-- begin field 86abd887-27f8-48f5-90e0-599e24ff8828 --><h3>Primary evidence</h3><!-- end field 86abd887-27f8-48f5-90e0-599e24ff8828 --><!-- begin field 2e17933b-7701-485e-af4b-8fde143e5957 --><p>No new randomized controlled trials published in the major journals since 1 May 2018.</p><!-- end field 2e17933b-7701-485e-af4b-8fde143e5957 --><!-- end item 7dbafcb8-1fb6-45e3-b4bd-a06a9839206b -->","subChapters":[]},{"id":"c0c00241-b5d8-5cc8-ad00-7c41d426ec60","slug":"new-policies","fullItemName":"New policies","depth":3,"htmlHeader":"<!-- begin field 10e00e6c-481e-4a59-8eb2-c52bff98b6cc --><h3>New policies</h3><!-- end field 10e00e6c-481e-4a59-8eb2-c52bff98b6cc -->","summary":null,"htmlStringContent":"<!-- begin item de4a8b16-af34-46b3-8fc0-9d89c196c9ef --><!-- begin field 8602baf2-ba3a-4fd2-abab-1e505d184463 --><p>No new national policies or guidelines since 1 May 2018.</p><!-- end field 8602baf2-ba3a-4fd2-abab-1e505d184463 --><!-- end item de4a8b16-af34-46b3-8fc0-9d89c196c9ef -->","subChapters":[]},{"id":"2bf13d83-3493-5e81-9e3a-b2cb27a60d20","slug":"new-safety-alerts","fullItemName":"New safety alerts","depth":3,"htmlHeader":"<!-- begin field a80ebd79-1f82-4884-ad03-4fee79e527d1 --><h3>New safety alerts</h3><!-- end field a80ebd79-1f82-4884-ad03-4fee79e527d1 -->","summary":null,"htmlStringContent":"<!-- begin item aaf8e675-da87-4108-9187-099e14b07f90 --><!-- begin field 18b3298f-477f-4a37-8baa-a26f4014cdc9 --><p>No new safety alerts since 1 May 2018.</p><!-- end field 18b3298f-477f-4a37-8baa-a26f4014cdc9 --><!-- end item aaf8e675-da87-4108-9187-099e14b07f90 -->","subChapters":[]},{"id":"c936ed04-327a-510c-bef1-4d1b88eb137f","slug":"changes-in-product-availability","fullItemName":"Changes in product availability","depth":3,"htmlHeader":"<!-- begin field 19193900-ecb8-4905-bf7e-5779cdaab0a1 --><h3>Changes in product availability</h3><!-- end field 19193900-ecb8-4905-bf7e-5779cdaab0a1 -->","summary":null,"htmlStringContent":"<!-- begin item a3499c6a-1d3b-4207-b443-3bfbb19fd5f3 --><!-- begin field acf57726-a8eb-4b1b-99cb-7ab9d1bd887b --><ul><li>FDA Approves Dermira’s Qbrexza for Treatment of Excessive Underarm Sweating. More info <a href=\"https://www.biospace.com/article/fda-approves-dermira-s-qbrexza-for-treatment-of-excessive-underarm-sweating/\" data-hyperlink-id=\"a246ec34-4886-41cc-b022-a91500aadbb9\">here</a>. </li></ul><!-- end field acf57726-a8eb-4b1b-99cb-7ab9d1bd887b --><!-- end item a3499c6a-1d3b-4207-b443-3bfbb19fd5f3 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}